Mice treated with cellular rejuvenation antiaging regimen in middle age demonstrate no increase in cancer or other health problems in later life.
Scientists at the Salk Institute, in collaboration with Genentech, a member of the Roche group, have shown that they can safely and effectively reverse the aging process in middle-aged and elderly mice by partially resetting their cells to more youthful states through cellular rejuvenation.
Longevity.Technology: Your genetic blueprint is not as fixed as you might think. Throughout your life, your DNA picks up a variety of chemical tags and markers that control which genes are switched on or off and to what degree they are expressed. This, in turn, controls the production of proteins in particular cells. These biochemical alterations accumulate from environmental influences (exposure to sunlight or pollution, &c), lifestyle factors (smoking, diet, amount of exercise) and from aging itself.
Although these epigenetic tags do not change the DNA sequence itself, they do alter the DNA’s operating instructions, as the epigenome alters the way cells that read and use the DNA’s instructions. The genetic ingredients stay the same, but the epigenetic recipe book changes with time, as notes are made, steps skipped or added and pages wear and tear and become harder to understand. Epigenetic markers can also be passed on from cell to cell, and sometimes from parent to child.
Adding a mixture of four reprogramming molecules – Oct4, Sox2, Klf4 and cMyc – to cells can reset these epigenetic marks to their original patterns. Using these molecules – Yamanaka factors – means scientists can dial back adult cells, from a cellular development point of view, into stem cells, effectively reprogramming them back into a youthful state.
In 2016, Izpisua Belmonte’s lab reported for the first time that they could use the Yamanaka factors to counter the signs of aging and increase life span in mice with a premature aging disease . More recently, the team found that, even in young mice, the Yamanaka factors can accelerate muscle regeneration. Following these initial observations, other scientists have used the same approach to improve the function of other tissues like the heart, brain and optic nerve, which is involved in vision.
In the new study, Izpisua Belmonte and his colleagues tested variations of the cellular rejuvenation approach in healthy animals as they aged. One group of mice received regular doses of the Yamanaka factors from the time they were 15 months old until 22 months, approximately equivalent to the ages of 50 to 70 in humans. Another group was treated from 12 to 22 months, approximately age 35 to 70 in humans. And a third group was treated for just one month, at age 25 months, similar to age 80 in humans .
“What we really wanted to establish was that using this approach for a longer time span is safe,” says Pradeep Reddy, a Salk staff scientist and co-first author of the new paper. “Indeed, we did not see any negative effects on the health, behavior or body weight of these animals .”
Compared with the control animals, there were no blood cell alterations or neurological changes in the mice that had received the Yamanaka factors; moreover, the team found no cancers in any of the groups of animals.
When the researchers looked at normal signs of aging in the animals that had undergone the treatment, they found that the mice, in many ways, resembled younger animals. In both the kidneys and skin, the epigenetic profile of the treated animals more closely resembled epigenetic patterns observed in younger animals. When injured, the skin cells of treated animals had a greater ability to proliferate and were less likely to form permanent scars – older animals usually show less skin cell proliferation and more scarring. Additionally, metabolic molecules in the blood of treated animals did not show normal age-related changes .
This youthfulness was observed in the animals treated for seven or 10 months with the Yamanaka factors, but not the animals treated for just one month. Moreover, when the treated animals were analysed midway through their treatment, the effects were not yet evident. This suggests that the treatment is not simply pausing aging, but winding back the clock, actively turning aging backwards – although more research is needed to differentiate between the two.
“We are elated that we can use this approach across the life span to slow down aging in normal animals. The technique is both safe and effective in mice,” says co-corresponding author Juan Carlos Izpisua Belmonte, professor in Salk’s Gene Expression Laboratory and holder of the Roger Guillemin Chair. “In addition to tackling age-related diseases, this approach may provide the biomedical community with a new tool to restore tissue and organismal health by improving cell function and resilience in different disease situations, such as neurodegenerative diseases .”
The team is now planning future research to analyse just how specific molecules and genes are changed by long-term treatment with the Yamanaka factors. They are also developing new ways of delivering the factors.
“At the end of the day, we want to bring resilience and function back to older cells so that they are more resistant to stress, injury and disease,” says Reddy. “This study shows that, at least in mice, there’s a path forward to achieving that .”.